With angry investors at the gates and thousands of lawsuits tied up in court, Bayer’s executives have scrambled to keep their head above water. Looks like relief isn’t coming any time soon, at least not in the courtroom. A California jury hit Bayer, which now sells glyphosate-based weed killer Roundup, with $ 2 billion in… Read More »
The opioid epidemic has long been a challenging issue both for Americans and the healthcare system that treats them, and the mortality statistics are significant. The American Academy of Family Physicians published research this year showing that, if there’s no change in the annual incidence of prescription opioid misuse, annual opioid deaths could hit 82,000… Read More »
Amarin CEO John Thero shrugged off the stock’s decline on Monday, telling CNBC that any investor concerned about its latest clinical trial should take a better look at the data.